X (Twitter) LinkedIn
    Sunday, December 3
    Login
    0 Shopping Cart
    X (Twitter) LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»IPO»General Atlantic-backed Centessa targets $1.7 bln valuation in U.S. IPO
    IPO

    General Atlantic-backed Centessa targets $1.7 bln valuation in U.S. IPO

    May 24, 20211 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Centessa Pharmaceuticals Plc, the newly formed biopharma company backed by private equity firm General Atlantic, said on Monday it was aiming for a valuation of up to $1.7 billion in its initial public offering in the United States.

    Formed in October, Centessa received $250 million funding in January. It is also backed by venture capital firm Index Ventures and life sciences-focused investment firm Medicxi.

    Moncef Slaoui, formerly the chief scientific adviser for the U.S. government’s Operation Warp Speed COVID-19 vaccine development program, joined Centessa as its chief scientific officer in February.

    Morgan Stanley, Goldman Sachs, Jefferies and Evercore ISI are the underwriters for the offering. Centessa said it would list on the Nasdaq under the symbol “CNTA”.

    Read More

    Source: Reuters

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    IPO PE Insider Private Equity
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Warburg Pincus surpasses target to close $17bn private equity fund

    October 18, 2023

    Brookfield banks $12B for its largest PE fund

    October 18, 2023

    Tech Giants Back Chip Designer Arm Holding’s $50 Billion Market Debut, Signaling a High-Stakes Realignment in Silicon Valley

    September 2, 2023

    Euroclear moves into $9.8 trillion private asset market with Goji buy

    December 21, 2022

    Comments are closed.

    Other Articles

    Parthenon Capital closes Fund VII at $4.5bn

    April 3, 2023

    KKR, EQT order fresh scans at Everlight Radiology

    January 19, 2021

    Permira Targets Over $15 Billion for New Flagship Fund

    May 11, 2021

    Neuberger Berman Appoints Sarah Peasey as London-Based Director of European ESG Investing

    September 6, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    X (Twitter) LinkedIn
    © 2023 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.


    Lost password?